Live News EQUITY FLASH L impact Oct 09, 2026, 01:20 PM UTC Guggenheim reiterates Buy on AbbVie, $288 price target Guggenheim reiterated a Buy rating on AbbVie and set a $288.00 price target. ABBV SquawkNews Desk